ARPA-H’s new lymphatic effort was announced on the same day as a $75.8 million program called OCULAB, which seeks to develop ...

ARPA-H award supports the development of an oral prodrug using Seaport’s proprietary Glyph™ platform to address dysfunctional ...

A team of researchers led by Rice bioengineer Omid Veiseh has been awarded up to $18.2 million in funding from the Advanced Research Projects Agency for Health to develop a first-of-its-kind ...

The Georgia Institute of Technology has been awarded up to $21.8 million from the Advanced Research Projects Agency for Health (ARPA-H) to deliver a first-of-its-kind therapy to patients with ...

Your veins and lymphatic system play an important role in circulating blood throughout your body. Normally, your heart pumps out fresh oxygenated blood and your veins bring it back. Over time, your ...

Seaport Therapeutics and MIPS awarded up to $15 mn from ARPA-H to advance Seaport’s GlyphCele, the first oral therapeutic designed to restore gut lymphatic function: Boston Thur ...

Scientists have made a breakthrough that could lead to effective treatments for lymphedema, a painful swelling condition for which there is currently no cure. Lymphedema can be congenital or caused by ...

Complementary to the circulatory system, the lymphatic system is a network of tissues and vessels that maintains fluid homeostasis, forms part of the immune system, and facilitates the absorption of ...

Imagine the body’s internal system suddenly acting sluggish; the body sends signs and signals that may appear as subtle imbalances at first, and later develop into major symptoms such as fatigue, a ...

A new study has found that light therapy applied to mice during deep sleep increased the brain’s ability to clear away beta-amyloid, a toxic protein linked to the development of Alzheimer’s disease.

Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage therapeutics company advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the award of an up ...